Barclays PLC Lensar, Inc. Transaction History
Barclays PLC
- $436 Billion
- Q2 2025
A detailed history of Barclays PLC transactions in Lensar, Inc. stock. As of the latest transaction made, Barclays PLC holds 16,770 shares of LNSR stock, worth $205,767. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,770
Previous 16,770
-0.0%
Holding current value
$205,767
Previous $221,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding LNSR
# of Institutions
84Shares Held
5.23MCall Options Held
46.8KPut Options Held
24K-
North Run Capital, LP Wellesley, MA1.1MShares$13.5 Million7.54% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA564KShares$6.92 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA506KShares$6.21 Million0.0% of portfolio
-
Groupe La Francaise Paris, I0251KShares$3.08 Million0.05% of portfolio
-
Paul Tudor Jones Tudor Investment Corp Et Al | Stamford, Ct237KShares$2.9 Million0.01% of portfolio
About LENSAR, Inc.
- Ticker LNSR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 11,021,000
- Market Cap $135M
- Description
- LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...